Hon. David Kappos

David J. Kappos is a partner at Cravath.  He is a leader in the field of intellectual property, including IP management and strategy, the development of global IP norms, laws and practices as well as commercialization and enforcement of innovation-based assets.  From 2009 to 2013, Mr. Kappos served as Under Secretary of Commerce and Director of the U.S. Patent and Trademark Office (USPTO).  In that role, he advised the President, the Secretary of Commerce and the Administration on IP policy matters.  Mr. Kappos led the Agency in dramatically reengineering its entire management and operational systems and its engagement with the global innovation community.  He was instrumental in achieving the greatest legislative reform of the U.S. patent system in generations through passage and implementation of the Leahy‑Smith America Invents Act, signed into law by President Obama in September 2011.

Prior to leading the USPTO, Mr. Kappos held several executive posts in the legal department of IBM, the world’s largest patent holder.  From 2003 to 2009, he served as the company’s chief intellectual property lawyer.  In that capacity, he managed global intellectual property activities for IBM, including all aspects of patent, trademark, copyright and trade secret protection and exploitation.  During his more than 25 years at IBM, he also served in a variety of other roles including litigation counsel and Asia Pacific IP counsel, where he led all aspects of IP protection, including licensing, transactions support and M&A activity for the Asia/Pacific region.

The United States Needs a National Standards Strategy

By Richard Taffet and Chris Borges Competition among nations for technological and economic leadership is intense, especially between the United States and the People’s Republic of China (PRC). The PRC has followed a decades-long, targeted strategy focused on leadership in critical and emerging technologies (CETs), and, according to some, it has
Read More

How Most-Favored Nation Policy Could Undermine U.S. Leadership

By Dr. Anne Pritchett The United States is the global leader in biopharmaceutical innovation. This leadership is built on the pillars of strong intellectual property protection, substantial investment in research and development (R&D), and a robust innovation ecosystem. These factors, combined with a market-based system that supports competitive drug pricing, encourage innovation and
Read More

U.S. Patenting Abroad — A Quiet Trade Advantage

By Chris Borges   Although patents are territorial, meaning they are limited to the jurisdiction in which they are granted, the networks spanning innovation and commerce are global. U.S. inventors routinely seek patent protection in markets abroad to safeguard their innovations, facilitate exports, and access new customers. By requiring member states
Read More